Spi Pharma

U.S.A

NDC Package Code : 58103-124

Start Marketing Date : 2017-09-29

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (93kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

02

ACETAMINOPHEN

U.S.A

SPI Pharma has been solving formulation challenges using superior functional materials.

U.S.A

NDC Package Code : 58103-115

Start Marketing Date : 2018-09-05

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (92kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

03

ALUMINUM HYDROXIDE; CARBON DIOXIDE

U.S.A

SPI Pharma has been solving formulation challenges using superior functional materials.

U.S.A

NDC Package Code : 12784-442

Start Marketing Date : 2019-12-09

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (61.5kg/100kg 5kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

04

ALUMINUM HYDROXIDE; CARBONATE ION; MAGNESIUM CARBONATE

U.S.A

SPI Pharma has been solving formulation challenges using superior functional materials.

U.S.A

NDC Package Code : 12784-420

Start Marketing Date : 2014-11-18

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (53kg/100kg 4.31/100kg 26kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

05

ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE

U.S.A

SPI Pharma has been solving formulation challenges using superior functional materials.

U.S.A

NDC Package Code : 12784-421

Start Marketing Date : 2020-01-27

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (64kg/100kg 161/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

06

ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE

U.S.A

SPI Pharma has been solving formulation challenges using superior functional materials.

U.S.A

NDC Package Code : 12784-451

Start Marketing Date : 2020-01-28

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (5.9kg/100kg 1.1kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

07

ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE

U.S.A

SPI Pharma has been solving formulation challenges using superior functional materials.

U.S.A

NDC Package Code : 12784-461

Start Marketing Date : 2023-08-04

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (5.9kg/100kg 1.1kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

08

ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE

U.S.A

SPI Pharma has been solving formulation challenges using superior functional materials.

U.S.A

NDC Package Code : 12784-460

Start Marketing Date : 2023-01-25

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (64kg/100kg 16kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

09

ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE

U.S.A

SPI Pharma has been solving formulation challenges using superior functional materials.

U.S.A

NDC Package Code : 12784-460

Start Marketing Date : 2024-09-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (64kg/100kg 16kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING

10

ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE

U.S.A

SPI Pharma has been solving formulation challenges using superior functional materials.

U.S.A

NDC Package Code : 67417-232

Start Marketing Date : 2015-05-18

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (20.5kg/100kg 42.9kg/100kg)

Marketing Category : DRUG FOR FURTHER PROCESSING